Rudy Lai

AI @ Cigna

Insurance and pharmacy benefits manager
Industry
Last updated
July 3, 2025 at 10:44 AM

Summary

  • Cigna has progressively expanded AI adoption from initial uses in patient adherence and outcomes (starting 2019-2021) to large-scale implementation of generative AI-powered digital tools and virtual assistants by mid-2025, enhancing customer service and operational efficiency.
  • Despite technological advances and launching multiple AI applications, including generative AI assistants and AI-powered claims tools, Cigna faces legal challenges and criticism due to AI's role in claim denials and reimbursement policies, raising concerns about fairness and accuracy.
  • Cigna is investing in precision healthcare AI coverage (e.g., cardiovascular imaging AI) and ethical AI governance frameworks, targeting improved patient outcomes, cost reduction, and customer experience, with early metrics showing significant user engagement and positive reception of AI digital assistants.

VIBE METER

More AI announcements = more VIBE
Q1 23Q2 23Q3 23Q4 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26🔥🔥🔥🔥

6 AI Use Cases at Cigna

Clinical Imaging
2025
Customer Facing
Traditional
Generative
Agentic
Outcome
Costs
Cigna covers AI-powered cardiovascular imaging solutions that analyze coronary plaque and improve diagnostic accuracy, thereby supporting clinical decisions and reducing healthcare costs. [1][2]
Virtual Assistance
2025
Customer Facing
Traditional
Generative
Agentic
Outcome
Cigna deployed generative AI-based virtual assistants that provide members with personalized, conversational answers regarding benefits, claims, and care options to enhance customer experience and engagement. [1][2][3]
Provider Matching
2025
Customer Facing
Traditional
Generative
Agentic
Outcome
Using AI to deliver personalized provider matching helps customers identify the most suitable healthcare providers based on personalized health data and preferences, improving decision making and satisfaction. [1][2]
Medication Monitoring
2024
Traditional
Generative
Agentic
Outcome
Risk
Cigna employs AI to monitor patient medication adherence and predict drug interactions, aiding pharmacists and care providers to optimize medication management and improve health outcomes. [1]
Claims Denial
2023
Traditional
Generative
Agentic
Outcome
Costs
Cigna utilizes AI algorithms to automatically assess and deny insurance claims based on predefined criteria, aiming to improve processing efficiency and reduce costs. This use case has raised legal and ethical concerns due to potential errors and fairness. [1][2][3]
Recruiting Optimization
2023
Traditional
Generative
Agentic
Outcome
Costs
AI is used internally at Cigna to enhance recruitment processes by making career opportunities more visible to employees and boosting internal hiring efficiency. [1]

Timeline

2026 Q1: no updates

2025 Q4

1 updates

Cigna announced a new transparent health plan called Clearity, integrating access to their AI assistant providing personalized, clear answers to coverage and cost questions, aiming to enhance member experience and transparency.

2025 Q3

3 updates

Cigna's new AI-driven Evaluation and Management Coding and Accuracy Reimbursement Policy to automatically downcode high-level claims using AI faced criticism from providers fearing inaccurate reimbursements and increased administrative burden. Meanwhile, Cigna expanded nationwide coverage for AI-powered cardiovascular imaging software from Heartflow and Cleerly, reflecting growing support for AI in precision cardiology and improved diagnostic value.

2025 Q2

5 updates

Cigna unveiled industry-leading generative AI-powered digital tools, including an AI virtual assistant providing personalized, conversational responses for benefits, claims, and care questions. Early adoption rates were strong (67% proactive use, 80% helpfulness). Additional AI tools like personalized provider matching, cost tracking, and smart claim submission were introduced, aiming to simplify health insurance navigation and improve customer experience. Simultaneously, lawsuits over AI-driven benefit denials proceeded, reflecting ongoing controversy.

2025 Q1

1 updates

Continued criticism surfaced regarding Cigna using AI for claim rejections, according to legal and media reports, raising questions about fairness and accountability.

2024 Q4: no updates

2024 Q3

3 updates

Expanded AI applications focused on pharmacists monitoring medication adherence, inventory management, prediction of drug interactions, and reducing providers' administrative burdens; strong emphasis on ethical AI governance.

2024 Q2: no updates

2024 Q1

1 updates

Cigna reported multiple AI use cases including enhancing customer service via predictive analytics and personalized healthcare solutions, demonstrating ongoing AI integration.

2023 Q4

2 updates

Legal scrutiny intensified over Cigna's AI-driven claims denial practices while the company also promoted AI-driven process improvements to streamline claim payouts with compliance.

2023 Q3

3 updates

Cigna expanded AI use in internal recruiting to boost employee hiring and introduced AI for claim assessment and denial processes. However, multiple lawsuits emerged alleging unfair claim denials powered by AI algorithms. The company also explored generative AI’s role in self-diagnosis, while committing publicly to ethical AI governance.

2023 Q2: no updates

2023 Q1: no updates

2022 Q4: no updates

2022 Q3: no updates

2022 Q2: no updates

2022 Q1: no updates

2021 Q4: no updates

2021 Q3

1 updates

Cigna utilized data and AI-driven analytics to improve patient outcomes, emphasizing outcome-driven insights without changing diagnoses directly.

2021 Q2: no updates

2021 Q1: no updates

2020 Q4: no updates

2020 Q3: no updates

2020 Q2: no updates

2020 Q1: no updates

2019 Q4

1 updates

Cigna expanded AI applications to identify treatment gaps, specifically monitoring patient medication adherence for chronic diseases.

2019 Q3

2 updates

Cigna began leveraging AI to tackle healthcare challenges and improve whole-person care. In Q4, it expanded AI to monitor patient medication adherence, particularly for chronic diseases.